Impaired Islet Function in Commonly Used Transgenic Mouse Lines due to Human Growth Hormone Minigene Expression by Brouwers, Bas et al.
Impaired islet function in commonly used transgenic mouse 
lines due to human growth hormone minigene expression 
Bas Brouwers 1, Geoffroy de Faudeur 2, Anna B. Osipovich 3, Lotte Goyvaerts 2, Katleen 
Lemaire 2, Leen Boesmans 2, Elisa J.G. Cauwelier 1, Mikaela Granvik 2, Vincent P.E.G. 
Pruniau 1, Leentje Van Lommel 2, Jolien Van Schoors 4, Jennifer S. Stancill 3, Ilse Smolders 4, 
Vincent Goffin 5, Nadine Binart 6, Peter in’t Veld 7, Jeroen Declercq 1, Mark A. Magnuson 3, 
John W.M. Creemers 1,*, Frans Schuit 2,* and Anica Schraenen 2 
1 Laboratory for Biochemical Neuroendocrinology, Department of Human Genetics, KU Leuven, 3000, 
Belgium 
2 Gene Expression Unit, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, 
Belgium 
3 Center for Stem Cell Biology and Department of Molecular Physiology and Biophysics, Vanderbilt 
University School of Medicine, Nashville, TN 37232, USA 
4 Center for Neurosciences, Department of Pharmaceutical Chemistry and Drug Analysis, Vrije 
Universiteit Brussel, Brussels, 1090, Belgium 
5 INSERM U845, Research Center Growth and Signaling, PRL/GH Pathophysiology Laboratory, 
University Paris Descartes, Sorbonne Paris Cité, Faculty of Medicine, Paris, 75993, France 
6 INSERM U693, Faculté de Médecine Paris-Sud, University Paris-Sud, Le Kremlin-Bicêtre, 94276, 
France 
7 Diabetes Research Center, Vrije Universiteit Brussel, Brussels, 1090, Belgium 
*Correspondence: Frans.Schuit@med.kuleuven.be (F.S.), John.Creemers@med.kuleuven.be (J.M.W.C) 
  
	  
	   	   	   2	  
	  
Summary 
The human growth hormone (hGH) minigene is frequently used in the derivation of 
transgenic mouse lines to enhance transgene expression. Although this minigene is present 
in the transgenes as a second cistron, and thus not thought to be expressed, we found that 
three commonly used lines; Pdx1-CreLate, RIP-Cre and MIP-GFP, each expressed significant 
amounts of hGH in pancreatic islets. Locally secreted hGH binds to prolactin receptors on β 
cells, activates STAT5 signaling, and induces pregnancy-like changes in gene expression 
thereby augmenting pancreatic β cell mass and insulin content. In addition, islets of Pdx1-
CreLate mice have lower GLUT2 expression, reduced glucose-induced insulin release and are 
protected against the β cell toxin streptozotocin. These findings may be important when 
interpreting results obtained when these and other hGH minigene-containing transgenic mice 
are used. 
Highlights 
• hGH drives Tph1 expression in islets from Pdx1-CreLate, RIP-Cre and MIP-GFP mice 
• Locally secreted hGH activates prolactin receptors on mouse β cells 
• Islets from Pdx1-CreLate mice have a pregnancy-like phenotype 
• hGH minigene is used in > 20 other islet-specific Cre-driver/transgenic models 
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Introduction 
Conditional inactivation of genes in mice by specific DNA recombination in target tissues was 
developed in the early nineties (Orban et al., 1992).  By then, it was already known that 
intronic sequences and a polyadenylation signal are essential to achieve efficient expression 
of the transgene (Brinster et al., 1988). The entire human growth hormone (hGH) coding 
region, including introns and polyadenylation signal - also called hGH minigene - was 
oftentimes inserted downstream of coding regions, such as that of Cre recombinase, to 
generate transgenic mouse models (Orban et al., 1992), some of which are in wide use 
today. 
Prolactin (PRL), placental lactogen (PL) and GH are homologous proteins that display 
overlapping structure (Goffin et al., 1996) and biological activities (Soares, 2004). The 
lactogens PRL and PL have a profound effect on the pancreatic islet phenotype of pregnant 
females (Parsons et al., 1992; Sorenson et al., 1987). During pregnancy, insulin resistance is 
induced in the mother, which facilitates nutrient flow towards the fetus (Freemark, 2006). To 
compensate for this increased metabolic demand and to prevent hyperglycemia, maternal 
pancreatic β cells undergo several structural and functional changes. These changes have 
been under investigation for several decades and involve multiple β cell parameters such as 
increased glucose-stimulated insulin secretion (GSIS) (Green and Taylor, 1972), enhanced β 
cell proliferation (Van Assche, 1974), accelerated proinsulin biosynthesis (Bone and Taylor, 
1976), higher rate of glucose oxidation and glucose utilization (Green et al., 1978; Weinhaus 
et al., 1996), and increased gap-junctional coupling of β cells (Sheridan et al., 1988). The 
importance of lactogens in this phenotypic switch has been demonstrated in mouse models 
in which β cell-specific overexpression of PL leads to enhanced insulin secretion and 
increased β cell mass (Fleenor et al., 2000; Vasavada et al., 2000). These signals are 
mediated by prolactin receptors (PRLR), as was demonstrated in Prlr+/- mice (Huang et al., 
2009). Growth hormones of primates, but not of other vertebrates, are also able to activate 
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PRLR, a property that is maintained in several heterologous systems (Goffin et al., 1996). 
Accordingly, it was shown that hGH can mimic the effects of lactogens on mouse and rat β 
cells (Parsons et al., 1995).  
To define the molecular basis of lactogen signaling during pregnancy, we and others recently 
explored the changes that occur in the gene expression using genome-wide mRNA 
expression analysis (Kim et al., 2010; Rieck et al., 2009; Schraenen et al., 2010a; Schraenen 
et al., 2010b). The largest cluster of upregulated genes during pregnancy regulates β cell 
mass (Schraenen et al., 2010a). In addition, a strong induction of the serotonin biosynthetic 
pathway was found in a subset of β cells (Schraenen et al., 2010b). Genes encoding 
tryptophan hydroxylases-1 (TPH1) and -2 (TPH2), catalyzing the rate-limiting step of 
serotonin biosynthesis, were found to be vastly upregulated (Kim et al., 2010; Schraenen et 
al., 2010b), resulting in a more than 100-fold increase in islet serotonin content. The 
responsible mechanism involved PRLR and activation of its canonical Janus kinase 2 
(JAK2)/signal transducer and activator of transcription 5 (STAT5) signaling pathway 
(Schraenen et al., 2010b). An autocrine/paracrine role for serotonin has been suggested in 
activating β cell proliferation via serotonin receptor 2B (Kim et al., 2010). 
Here we describe unexpected functional consequences resulting from the placement of hGH 
minigene in the transgenic constructs. The principal mouse strain used for these studies was 
the Tg(Pdx1-cre)1Herr mouse strain, also known as the Pdx1-CreLate model (Herrera, 2000). 
This transgenic line contains a 4.5 kb fragment of the Pdx1 promoter, inserted upstream of 
the Cre recombinase-coding region and an hGH minigene in order to achieve efficient 
transgene expression. We studied the expression of hGH at the mRNA and protein level and 
the consequences for islets from Pdx1-CreLate mice such as changes in β cell mass and 
insulin secretion. In addition, we examined hGH expression and serotonin biosynthesis in 
two other lines that are frequently used for pancreatic islet research: the C57BL/6-Tg(Ins2-
cre)25Mgn/J line (Postic et al., 1999), which is frequently used to generate β-cell conditional 
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gene knockouts, and the B6.Cg-Tg(Ins1-EGFP)1Hara/J line, which is often used to visualize 
and/or purify pancreatic β-cells (Hara et al., 2003), from now on referred to as RIP-Cre and 
MIP-GFP, respectively.  
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Results 
Pancreata from Pdx1-CreLate mice have increased β cell mass and insulin content 
While working with the Pdx1-CreLate driver line to generate a new β cell-specific knockout 
strain, we found that circulating blood glucose, both in the random fed (Figure 1A) and fasted 
state (Figure 1B), was lower in the Pdx1-CreLate mice than in littermate controls. This 
difference could not be explained by enhanced insulin sensitivity of Pdx1-CreLate mice (Figure 
1C). Instead, we observed an increase in pancreatic β cell mass (Figure 1D), which was 
accompanied by a nearly doubled pancreatic insulin content (Figure 1E, Pdx1-CreLate 390±19 
µg/g vs WT 204±52 µg/g, n=9-10/genotype, p=0.006). 
Paracrine/autocrine PRLR activation by hGH in islets from non-pregnant Pdx1-CreLate mice 
In the original description of the Pdx1-CreLate mouse model (Herrera, 2000), the complete 
coding hGH gene sequence, including exons, introns and its polyadenylation signal, is 
present downstream of the Pdx1 promoter and Cre recombinase (Figure 2A). Results from 
Figures 2B-F demonstrate that the hGH minigene is specifically and highly expressed in 
mouse β cells of the Pdx1-CreLate strain. We quantified hGH expression both at the mRNA 
level (Figure 2B) and protein level (Figure 2C-E). We found significant hGH expression only 
in pancreatic islets but not in the other tissues (Figure 2B) including the exocrine part of the 
pancreas (Figure 2D). Western blots (Figure 2C) indicated that the mature hormone of the 
expected molecular weight (22kDa) was produced in Pdx1-CreLate islets. Quantification of 
hGH in extracts from isolated islets and in conditioned medium (Figure 2F) show that 
approximately 4% of cellular hGH content is released per hour from 20 mM glucose-
stimulated Pdx1-CreLate islets. Figure 2G supports the idea that locally secreted hGH has 
functional effects on pancreatic islet in vivo. Indeed, a significant increase (3.7-fold, n=3, 
p=0.005) in STAT5 phosphorylation was detected in freshly isolated Pdx1-CreLate islets 
compared to control islets (Figure 2G). Because hGH can bind to GH receptors (GHR) and to 
PRLR (Goffin et al., 1996), and since both receptors are strongly expressed in rodent β cells 
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(Brelje et al., 2002; Møldrup et al., 1993), we next investigated the mechanism via which 
hGH causes phenotypic changes in β cells. We first used MIN6 cells as a surrogate model 
for mouse β cells (Miyazaki et al., 1990) and quantified Tph1 as a marker for lactogen-
mediated PRLR activation, taking ovine PL (oPL) as a positive control (Schraenen et al., 
2010b). As is shown in Figure 2H, both hGH and oPL were very potent ligands in this assay 
as a significant induction of Tph1 mRNA was already observed with 25 ng/ml (∼1 nM). In 
comparison, the minimal effective concentration of mouse (m)GH, which only binds to GHR, 
was 500 ng/ml, indicating that synthetic hGH was at least 20-fold more potent. Similar results 
were obtained with primary islets: a significant induction of Tph1 mRNA was found in islet 
monolayers treated with 500 ng/ml oPL or hGH, but not after treatment with mGH (Figure 2I). 
To confirm that hGH stimulation of Tph1 expression is mediated by PRLR signaling, MIN6 
cells stimulated or not with 25 ng/ml hGH were co-treated with increasing concentrations of 
the synthetic PRLR antagonist Δ1-9-G129R-hPRL (Bernichtein et al., 2003). A concentration-
dependent antagonism was observed (Figure 2I). Together, our data indicate that lactogen-
like increment of pancreatic β cell mass and insulin content in Pdx1-CreLate mice is initiated by 
local hGH release and mediated by activation of PRLR. 
Activation of a pregnancy-related phenotypic switch in islets from Pdx1-CreLate mice 
The autocrine/paracrine PRLR stimulation by local release of hGH in pancreatic islets not 
only enhanced the β cell mass but also upregulated more than 100 genes that are also 
upregulated in islets from C57BL/6J pregnant mice (Figure 3A). This was measured by 
comparison of the global islet gene expression profile in 12-week-old Pdx1-CreLate mice and 
control non-pregnant littermates as well as islet from C57BL/6J pregnant mice not carrying 
the Pdx1-CreLate insertion. More than 50% (121/218) of the upregulated genes in non-
pregnant Pdx1-CreLate islets were also upregulated during pregnancy (Figure 3A). Overlap 
was complete for a pregnancy gene expression signature, consisting out of 12 known genes 
described previously to be highly upregulated during pregnancy (fold increase ≥ 3 and 
P<0.001 at pregnancy day 12.5) (Figure S1). For this strongly induced pregnancy gene 
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expression signature we confirmed by quantitative RT-PCR (qRT-PCR) analysis that the 
mRNA signal in Pdx1-CreLate islets was significantly higher than in control islets (Figure 3B). 
The two transcripts that encode the non-allelic paralogs of tryptophan hydroxylase, Tph1 and 
Tph2, were highly induced in Pdx1-CreLate islets, respectively, 346.3 ± 69.4-fold (p=0.004) 
and 14.3 ± 3.2-fold (p=0.011). To assess the importance of the PRLR in the pregnancy 
switch in vivo, expression of the 12 genes in the gene expression signature was quantified in 
islets from Pdx1-CreLate;PRLR-/- mice versus Pdx1-CreLate littermates, by qRT-PCR. A 
significant reduction in gene expression was observed for most of the 12 genes in the Pdx1-
CreLate;PRLR-/- mouse model as compared to Pdx1-CreLate controls (Figure 3C), again 
stressing the crucial role of the PRLR in the pregnancy switch. 
Because DOPA decarboxylase, the second enzyme needed for serotonin biosynthesis from 
tryptophan, is constitutively and highly expressed in mouse pancreatic islets, the strong 
upregulation of the tryptophan hydroxylase step indicates that islets of Pdx1-CreLate mice are 
competent to synthesize serotonin under non-pregnant condition. This is in contrast to 
control mice, which only produce serotonin during pregnancy. Therefore, we quantified islet 
serotonin content of control and Pdx1-CreLate mice under non-pregnant condition and 
observed a striking difference (Figure 3D). This difference between mouse genotypes 
contrasted with islet gamma-amino butyric acid (GABA) (Figure 3E), a neurotransmitter that 
is constitutively produced by decarboxylation of glutamate in rodent and human β cells 
(Sorenson et al., 1991). Consequently, the islet serotonin/GABA molar ratio increased by at 
least one order of magnitude in islet extracts from the non-pregnant Pdx1-CreLate strain 
(Figure 3F). To analyze the serotonin production at the cellular level in non-pregnant Pdx1-
CreLate mice, we performed immunostaining on pancreatic islet sections. A heterogeneous 
pattern of serotonin immunoreactivity was found in islet β cells of non-pregnant Pdx1-CreLate 
mice (Figure 3G), similar to the production observed in wild type C57BL/6J mice during 
pregnancy (Schraenen et al., 2010b). No serotonin immunoreactivity was detected in non-
pregnant control mice. Together, these data show that the normal serotonin biosynthetic 
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pathway, observed in a subpopulation of β cells in the pancreas of pregnant mice, is induced 
independently of pregnancy in islets from Pdx1-CreLate mice. 
Impaired glucose tolerance and reduced islet GLUT2 expression in Pdx1-CreLate mice 
Overlap between genes that are downregulated in islets from pregnant wild type C57BL/6J 
mice versus non-pregnant Pdx1-CreLate mice was much weaker (Figure 3A). One example 
was the mRNA encoding the glucose transporter GLUT2, which was repressed in Pdx1-
CreLate islets (Figure 4A) but not in islets from pregnant mice. GLUT2 acts as a glucose 
sensor protein in rodent pancreatic β cells and is essential for normal glucose homeostasis in 
mice (Guillam et al., 1997; Thorens et al., 1988). This reduction in Glut2 mRNA expression 
correlated with a strong reduction in immunoreactive protein on islet β cell membranes 
(Figure 4B) but contrasted with that of other genes involved in GSIS which remained at the 
control level in islets isolated from in Pdx1-CreLate mice (Figure S2A). The reduction of 
GLUT2 expression also coincided with a partial loss of GSIS with either 20 mM glucose or 20 
mM glucose plus the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) as well 
as higher basal release (Figure 4C). This abnormality was associated with a slightly 
decreased glucose tolerance (Figure 4D) and lower circulating insulin levels (Figure 4E) after 
2.5 mg/g body weight (BW) intraperitoneal (i.p.) glucose injection. Glucose intolerance was 
even more pronounced in older Pdx1-CreLate mice (20-week-old) (Figure S2B). However, 
glycemia turned back to starting levels at the same time point as control mice. Together, 
these data indicate that, in addition to some pregnancy-related phenotypic changes, local 
release of hGH induces other changes in pancreatic islets, as exemplified by reduced 
GLUT2 and partial loss of GSIS in Pdx1-CreLate islets. 
Pdx1-CreLate mice are protected against the diabetogenic toxin streptozotocin 
The GLUT2 transporter on the β cell surface is also responsible for the uptake of the β cell 
toxin streptozotocin (STZ) (Schnedl et al., 1994). Consequently, in control mice, which have 
very high levels of GLUT2 expression on β cells, STZ can induce an acute β cell necrosis 
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after single injection of a high dose or chronically after multiple low dose injections (Lenzen, 
2008). As the Glut2 gene expression is reduced in Pdx1-CreLate islets, the effect of STZ might 
be diminished. Moreover, PRL-induced activation of the JAK2/STAT5 pathway was reported 
to protect mice against multiple-low doses of STZ (Holstad and Sandler, 1999; Jackerott et 
al., 2006). The effect of these two protective changes in islets of Pdx1-CreLate mice on blood 
glucose levels was tested in the multiple low dose STZ model (50mg/kg BW for 5 
consecutive days and one month follow up of blood glucose levels - Figure 4F) as well as in 
the single high dose STZ model (150 mg/kg BW and 5 days of follow up - Figure 4G). Pdx1-
CreLate mice remained normoglycemic during the whole follow-up period in both models, 
whereas all control animals developed diabetes. However, the protection of Pdx1-CreLate 
mice against a single high dose STZ injection was completely lost when Pdx1-CreLate mice 
were crossed to Prlr-/-, further emphasizing the involvement of the PRLR in the hGH-induced 
phenotypic changes observed in Pdx1-CreLate mice (Figure 4H).  
hGH and serotonin production also occurs in islets from RIP-Cre and MIP-GFP mice.  
Since many transgenic mouse models, in addition to the Pdx1-CreLate animals, incorporated a 
hGH minigene in their design (see Table 1), we also examined whether hGH protein is 
produced in MIP-GFP and RIP-Cre islets, two transgenic lines that are commonly used in 
studies of β cell biology and cellular mechanisms of diabetes. While expression of the hGH 
mRNA was expected given the placement of the gene sequences in the transgene construct 
(Figure 5A) hGH protein immunoreactivity was also observed (Figure 5B and S3).  
Furthermore, we found evidence for a pregnancy related phenotypic switch as illustrated by a 
strong induction of Tph1 mRNA (Figure 5A) and immunoreactive serotonin in islets from MIP-
GFP and RIP-Cre islets (Figure 5C and quantified in Figure S4). Therefore, the presence and 
functional activity of hGH protein is not limited to Pdx1-CreLate mice but also occurs in these 
two other lines. Similar to what was observed in the Pdx1-CreLate mice, 9-week-old MIP-GFP 
mice had lower blood glucose levels after an overnight fast (Figure S5A) and lower plasma 
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insulin levels 30 min after start of the glucose tolerance test (Figure S5B-C), whereas insulin 
sensitivity was normal (Figure S5D). 
Discussion 
The Cre/LoxP system is a powerful tool to conditionally inactivate or overexpress genes in 
transgenic animals with a number of specific advantages over whole-body knockouts. 
However, there have been many reports describing specific limitations of some Cre driver 
strains. These include variegated Cre expression in target organs (Gannon et al., 2000; 
Ryding et al., 2001), ectopic expression in undesired tissues (Delacour et al., 2004; Song et 
al., 2010; Wicksteed et al., 2010), and unwanted effects related to the integration site 
(Cartwright and Wang, 2009). For central nervous system and pancreas-specific Cre driver 
lines, these limitations and their likely causes have been recently reviewed in (Harno et al., 
2013; Magnuson and Osipovich, 2013). In particular for the RIP-Cre mouse model (Postic et 
al., 1999), a multi-center study showed glucose intolerance in these mice in the absence of 
genes targeted by loxP sites (Lee et al., 2006). Moreover, younger RIP-Cre mice exhibited β 
cell hypoplasia, whereas older mice showed β cell hyperplasia (Pomplun et al., 2007).  
In the present study, we describe a previously unrecognized mechanism whereby inclusion 
of an hGH minigene as a component of the transgene construct can impair β-cell function.  
While use of an hGH minigene has long been thought to be inconsequential due to it being 
the second cistron in the transgene-encoded mRNA, and should not be expressed, our 
studies provide compelling data otherwise. Expression of hGH may have a profound 
influence on the interpretation of certain types of experiments, especially those pertaining to 
the control of pancreatic β cell mass and the regulation of insulin secretion, both of which are 
very active fields of diabetes research.  
In islets from Pdx1-CreLate, the MIP-GFP and the RIP-Cre mouse models we observed 
expression of hGH from the hGH minigene sequences placed downstream of the Cre or GFP 
coding regions (Brinster et al., 1988). As a result, hGH of the expected molecular weight (22 
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kDa) is synthesized and secreted from islets of these mice, causing Cre-or GFP-independent 
effects by autocrine/paracrine stimulation of β cells. An insertional effect has been postulated 
before (Lee et al., 2006; Pomplun et al., 2007), but is unlikely since we observe Tph1 
expression and serotonin immunoreactivity in two other frequently used mouse lines (RIP-
Cre and MIP-GFP). Figure 6 proposes a model in which locally secreted hGH acts as a 
lactogen by activating abundantly expressed PRLR on mouse β cells and initiating the 
JAK2/STAT5 signaling pathway. A first group of effects is therefore pregnancy-like and 
includes induction of serotonin biosynthesis and a doubling of β cell mass and pancreatic 
insulin content. The most important of pregnancy-unrelated effects is a partial loss of GSIS, 
decreasing glucose tolerance. This loss of function could be partially caused by 
downregulation of GLUT2, a transporter responsible for the rapid equilibration between extra- 
and intracellular glucose concentration and thus the first step of glucose sensing in rodent 
islets (Guillam et al., 1997). This is in contrast with the pregnancy state, as β cell Glut2 levels 
have been reported to increase as part of the adaptive maternal response (Weinhaus et al., 
1996). GLUT2 is also needed for rapid uptake of the β cell toxins STZ (Schnedl et al., 1994) 
and alloxan (De Vos et al., 1995), so it seems reasonable to attribute the protection of Pdx1-
CreLate islets against STZ-induced diabetes to reduced toxin uptake rates caused by less 
GLUT2 channels (Figure 5). In addition, enhanced β cell mass and greater potential to 
regenerate new β cells may also be involved. 
As the hGH minigene is frequently used to enhance expression of transgenes, we did a 
literature search for mouse lines generated using the same genetic strategy (Table 1). At the 
time of preparation of this manuscript, we listed a total of 22 mouse models. Due to the lack 
of information available for several other β-cell-specific mouse strains, our table may be an 
underestimation of the total amount of models involved. In some of the models listed in Table 
1 expression of the hGH minigene was mentioned, either at the level of mRNA (Miyazaki et 
al., 2010; Postic et al., 1999; Sanvito et al., 1995) or immunoreactive protein (Klee et al., 
2011). In none of them, however, the potential influence on pancreatic islet morphology, β 
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cell function or glucose homeostasis was considered.   
The investigation of cellular and physiological mechanisms that regulate β cell mass and β 
cell function is currently a very active area of diabetes research that makes extensive use of 
genetically altered mice. Moreover, there is already a large body of experimental work that 
has made use of mice containing hGH minigene. Our current observations seem therefore to 
have potential implications on the interpretation of a large body of published data, in 
particular with respect to changes in functional β cell mass, insulin secretion and protection 
against the diabetogenic effect of STZ. 
 
Experimental procedures 
Mice 
Pdx1-CreLate transgenic mice (Herrera, 2000)(Dr. Herrera, University of Geneva, Switzerland) 
were crossed with C57BL/6J (Janvier) for at least eight generations. PRLR knockout mice 
(designated Prlr-/-) on a 129Sv background were described previously (Freemark et al., 
2002). Pdx1-Crelate females were bred with Prlr+/- males to generate Pdx1-CreLate; Prlr+/- mice, 
which were subsequently crossed with Prlr+/- to obtain Pdx1-CreLate; Prlr -/- mice. Institutional 
guidelines for animal welfare and experimental conduct were followed. All experiments with 
laboratory animals were approved by the committee for animal welfare at the KU Leuven.  
RIP-Cre mice (Postic et al., 1999) and MIP-GFP mice (Hara et al., 2003) were maintained on 
C57Bl and CD1 backgrounds respectively. All animal procedures and husbandry were 
approved by the Vanderbilt University Institutional Animal Care and Use Committee. 
Cell cultures 
MIN6 cells were incubated in DMEM (25 mmol/l glucose, 2% FCS, 4 mmol/l glutamax) 
(Invitrogen-Gibco) with hGH (Calbiochem), mGH or oPL (Prospec). For the experiments with 
	  
	   	   	   14	  
	  
the PRLR-antagonist Δ1-9-G129R-hPRL MIN6 cells were pre-incubated for 30 min with the 
antagonist. Thereafter, recombinant hGH (from Vincent Goffin) was added to the medium. 
Twenty-four hours later RNA was extracted. 
Islet isolation 
Pancreatic islets were isolated after infusion and digestion of the pancreata by collagenase P 
(Roche) as described previously (Lemaire et al., 2009).  
Islet monolayers 
Islet monolayers were performed as previously described (Schraenen et al., 2010b). Isolated 
islets were cultured for 7 days in RPMI medium (10% [vol./vol.] decomplemented FCS, 100 
U/ml penicillin, 100 µg/ml streptomycin, 4 mmol/l glutamax, 10 mM HEPES pH 7.4) to form 
monolayers.  On day 7, they were stimulated with 0 or 500 ng/ml oPL, mGH or hGH.  
Microarray expression analysis 
Microarray analysis was performed on RNA of isolated islets using MoGene_1.0_ST arrays 
(Affymetrix). For RNA extraction, see Extended Experimental Procedures. Total islet RNA 
(100 ng) was used to hybridize the arrays according to manufacturer’s manual 701880Rev4 
as described previously (Lemaire et al., 2009). Samples were analyzed pair-wise, using 
p<0.001 and fold change≥1.5 as selection criteria. A list of up- and down regulated genes in 
islets isolated from Pdx1-CreLate transgenic mice versus control mice is provided as an excel 
table (see Table S1) and genes related to pregnancy are marked. 
Quantitative RT-PCR  
Following cDNA synthesis using a reverse transcriptase kit (RevertAid H Minus; Fermentas), 
qRT-PCR (Absolute QPCR mix; Abgene-Thermo Fisher Scientific) was performed on a 
Rotorgene (Corbett Research).   For primers and probes see Extended Experimental 
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Procedures. For Tph2 a Taqman gene expression assay (Mm00557717_m1; Applied 
Biosystems) was used. When a probe was used data was analyzed according to the Pfaffl 
method, without delta Ct was used.  
Histology 
Pancreata were fixed overnight in 4% formaldehyde and embedded in paraffin. Sections 
were rehydrated and heated for 20 minutes in Target Retrieval Solution (pH 6.1, Dako). After 
blocking with 20% normal goat serum (Dako) in PBS, slides were incubated with 1/1,000 
anti-hGH monoclonal (ab15317, Abcam) antibody in Antibody Diluent (Dako). For double 
immunofluorescent labeling, 1/50,000 rabbit anti-serotonin (Immunostar, #20080) or 1/2000 
polyclonal anti-GLUT2 (07-1402, Millipore) was combined with 1/10,000 diluted guinea-pig 
anti-insulin antibody (a gift of Dr. Van Schravendijk, VUB, Brussels) and detected with anti-
rabbit Cy3 and anti-guinea-pig FITC respectively (both from Jackson Immunoresearch 
laboratories). For MIP-GFP and RIP-Cre mice, frozen sections were stained with 1/10,000 
rabbit anti-serotonin or 1/200 mouse anti-hGH (blocking with Mouse on Mouse (M.O.M.) 
Basic Kit from Vector Labs) and co-stained with 1/2000 guinea pig anti-insulin in sections 
from RIP-Cre mice. For MIP-GFP, direct fluorescence for GFP was used to detect β cells. 
Glucose (GTT) and insulin tolerance tests (ITT)  
Overnight (GTT) or 6-hour-fasted (ITT) mice were injected i.p. with 2.5 mg/g BW D-glucose 
or 0.75 mU/g BW human insulin, respectively and glycemia was measured by tail-blood 
analysis using a Contour glucose meter (Bayer). For GTT, tail-blood was collected at the 
indicated time-points and plasma was analyzed. 
Islet serotonin and GABA content 
80 islets were homogenized by 3 min sonication in a buffer containing 0.01 mol/l HCl, 1 
mmol/l EDTA and 4 mmol/l sodium metabisulfite. After centrifugation (20,000 g) for 15 min at 
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4°C and addition of 0.1% (wt/vol.) ascorbic acid (Acros), lysates were stored at −80°C. 
Serotonin and GABA concentrations were determined via HPLC see Extended Experimental 
Procedures. 
Islet hGH content and release 
Freshly isolated islets were incubated in batches of 100 at 37°C. Incubation was in HEPES 
Krebs buffer (20 mmol/l HEPES, pH7.4; 119 mmol/l NaCl; 4.75 mmol/l KCl; 2.5 mmol/l 
CaCl2; 1.2 mmol/l MgSO4; 1.2 mmol/l KH2PO4; 5 mmol/l NaHCO3, 0.5% [wt/vol.] BSA) 
containing 20 mmol/l glucose. After 1 hour, half of the medium was removed for 
measurement of hGH release. For the content, Triton-X-100 (final concentration: 0.5%) was 
added to the other half of the medium with the islets. Islets were sonicated for 3 minutes and 
lysates were stored at −20°C. To measure concentrations an hGH ELISA was used 
(Invitrogen). 
Islet insulin content and release 
For insulin secretion measurements, size matched islets (n = 5 per tube) were placed in 
glass tubes containing HEPES Krebs solution containing 0.5 % BSA, supplemented with 
glucose 5 mM (G5), 20mM (G20) or G20 with 250 µM IBMX. Supernatant was collected after 
1 hour incubation at 37°C. The islets were sonicated for 3 min after adding Acid ethanol (final 
concentration: 75 % EtOH, 0.1 N HCl, 1% triton). Samples were stored at -20°C and the 
ELISA kit used for insulin determination was from Crystal Chem. 
Total pancreas insulin content 
Pancreata were dissected and acid-ethanol extracts were diluted 1/1000 in PBS and 
analyzed for insulin using an insulin high-range ELISA (Mercodia). Absolute insulin content 
per pancreas as well as relative content (corrected for pancreas weight) was quantified. 
β cell mass quantification 
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Total pancreas from 24-week-old Pdx1-Crelate and littermate control mice (4 males per group) 
was processed and six sections separated by 200 µm were stained for insulin as described 
above. The total surface area of insulin positive cells (in pixels) was quantified with Zeiss 
Axiovision software (Micro Imaging). The relative insulin surface area per section (total 
insulin area (pixels)/total pancreas area (pixels)) was multiplied by the pancreas weight (mg) 
to obtain the β cell mass (mg). 
Western blot  
Islets were isolated as described above and homogenized in lysis buffer (Cell Signaling 
Technology) by sonication. Protein extracts were separated by SDS-PAGE (10% [vol./vol.] 
Bis/Tris gel; Life Technologies), blotted on a nitrocellulose membrane, blocked in 4% 
[wt./vol.] milk and incubated with primary antibody (anti-hGH, ab15317, 1/1000; anti-GAPDH, 
1/15,000; clone 6C5, both from Abcam). The blot was subsequently incubated with 
peroxidase-conjugated secondary antibody (Dako) and proteins were detected using the 
Western Lightning ECL system (PerkinElmer). For hGH staining on islets from MIP-GFP and 
RIP-Cre mice, a similar protocol was used with adjustments; 10 µg of islet protein sample in 
1X Laemmli sample buffer was resolved on 15% SDS-PAGE and transferred to 
polyvinylidene difluoride membranes (EMD Millipore). 
Statistical methods 
When not differently stated in the legend or text, data are presented as mean ± SEM and 
significance shown on graphs as p<0.05*, p<0.01** or p<0.001. 
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Figure legends 
Figure 1 Increased β cell mass and insulin content in non-pregnant Pdx1-CreLate mice. 
(A-B) Blood glucose levels in (A) random fed and (B) fasted Pdx1-CreLate versus control mice. 
Data are represented as mean ± SEM, n=7 mice per genotype, **P<0.01. 
(C) Insulin tolerance test (ITT) on 10 week-old Pdx1-CreLate versus control mice. Values are 
presented as percentage compared to starting glucose level. Data are represented as mean 
± SEM, n=7-8 mice per genotype. 
(D) Quantification of β cell mass in 24-week-old Pdx1-CreLate versus control mice, performed 
as described in ‘Experimental Procedures’. Data are represented as mean ± SEM, n=4 mice 
per genotype, **P<0.01. 
(E) Pancreatic insulin content in 24-week-old Pdx1-CreLate versus control mice. Data are 
represented as mean ± SEM, n=9-10 mice per genotype, **P<0.01. 
Figure 2 Pregnancy-related phenotypic changes are caused by local production and 
secretion of hGH in islets from non-pregnant Pdx1-CreLate mice. 
(A) Schematic representation of the Pdx1-Cre construct used to generate the Pdx1-CreLate 
mouse model. A 4.5 kb Pdx1 promoter fragment was inserted upstream of the Cre 
transgene. The hGH minigene, containing introns, exons and polyadenylation signal, is 
located directly downstream of the Cre fragment and indicated in red. Figure adapted from 
(Herrera, 2000).  
(B) qRT-PCR analysis of hGH mRNA in different tissues including isolated islets from control 
and non-pregnant Pdx1-CreLate mice. Data were quantified as delta Ct values (relative to 
Gapdh). Data are represented as mean ± SEM, n=3-6 per condition, ***P<0.001. 
(C) Western blot analysis of hGH expression in islets of control and non-pregnant Pdx1-
CreLate mice. GAPDH was used as a loading control. 
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(D) Immunoreactive hGH in pancreatic sections from control and non-pregnant Pdx1-CreLate 
mice. The hGH signal is most intense in pancreatic islets and not uniformly distributed over 
their different islet cells. Scale bar = 100 µm. 
(E-F) Quantification of hGH content (panel E) and release (panel F; measured as % of 
cellular content per hour) in islets isolated from Pdx1-CreLate mice. For the release 
experiments, isolated islets were incubated with 20 mM D-glucose for 1 hour. Data are 
represented as mean ± SEM, n=3 per condition, **P<0.01. 
(G) Representative immunoblot of islet phospho-STAT5 (P-STAT5) and total STAT5 protein 
in islets from control and non-pregnant Pdx1-CreLate mice. GAPDH was used as a loading 
control. Mean density ratios of P-STAT5/total STAT5 were 3.72 ± 0.38-fold increased in 
Pdx1-CreLate islets compared to controls. Data are represented as mean ± SEM, n=3 per 
condition, P=0.005. 
(H-I) Induction of Tph1 expression in MIN6 cells (H) and primary islet monolayers (I) by hGH 
and oPL. Cells were treated with the indicated concentrations of oPL, mGH or hGH, and islet 
monolayers with vehicle (control) or 500 ng/ml oPL, mGH or hGH. Expression of Tph1 was 
quantified by qRT-PCR. Polr2a was used as a reference gene. Data was calculated via the 
Pfaffl method and the ratio of the control sample was normalized to 1. Data are represented 
as mean ± SEM, n=3-5 independent measurements per condition; *P<0.05, **P<0.01, 
***P<0.001. 
(J) Inhibition of hGH-induced Tph1 expression in MIN6 cells by a specific PRLR inhibitor. 
MIN6 cells pre-incubated (30 min) with different concentrations of PRLR-antagonist Δ1-9-
G129R-hPRL were stimulated with 0 or 25 ng/ml hGH; Tph1 mRNA expression was used as 
read-out for the pregnancy signature and Polr2a was used as a reference gene. Data was 
calculated via the Pfaffl method and the average-ratio of 0 ng/ml hGH was set to 1. Data are 
represented as mean ± SEM, n=3 per condition *P<0.05, **P<0.01. 
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Figure 3 Pregnancy-related phenotypic switch in islets isolated from non-pregnant 
Pdx1-CreLate mice. 
(A) Microarray analysis of islet mRNA expression. A substantial overlap of > 100 differentially 
expressed genes (P<0.001 and fold change of ≥ 1.5) was found when comparing pregnant 
versus non-pregnant mice on the one hand (left) and non-pregnant Pdx1-CreLate mice versus 
non-pregnant control mice on the other hand (right). This overlap contains almost 10-fold 
more up- than down-regulated genes. 
(B) qRT-PCR analysis of the pregnancy gene signature in non-pregnant Pdx1-CreLate versus 
control mice. For each of the top 12 upregulated genes during pregnancy at P12.5, we 
observed significant upregulation in islets from non-pregnant Pdx1-CreLate mice. Polr2a was 
used as a reference gene. Data was calculated via the Pfaffl method and the average-ratio of 
each gene was set to 1 for the control mice. Two strongly induced genes in islets from Pdx1-
CreLate mice encode the two isoforms of tryptophan hydroxylase (TPH1 and TPH2). Data are 
represented as mean ± SEM, n=4-6 per group, *P<0.05, **P<0.01, ***P<0.001. 
(C) qRT-PCR analysis on all 12 genes from the pregnancy gene expression signature, in 
islets from Pdx1-CreLate;PRLR-/- mice versus Pdx1-CreLate littermates n=3 mice per genotype. 
Data are represented as mean ± SEM, n=3 per group, *P<0.05, **P<0.01, ***P<0.001. 
(D-F) Quantification of serotonin and GABA in islets isolated from non-pregnant control and 
non-pregnant Pdx1-CreLate mice. (D) Basal islet serotonin levels are near the detection limit 
of the assay in control mice and dramatically upregulated in non-pregnant Pdx1-CreLate mice. 
(E) In contrast, GABA is as abundant in islets of control as in islets of non-pregnant Pdx1-
CreLate mice. (F) Consequently the molar serotonin/GABA ratio is about 100-fold higher in 
islets from Pdx1-CreLate mice compared to control islets. Data are represented as mean ± 
SEM, n=5-6 per group, *P<0.05, **P<0.01, ***P<0.001. 
(G) Heterogeneous serotonin immunoreactivity in islets from non-pregnant Pdx1-CreLate 
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mice. No serotonin immunoreactivity is detected in control mice, while in non-pregnant Pdx1-
CreLate mice serotonin is only present in islet β cells with marked differences between 
neighboring β-cells. Data are representative sections from pancreata analyzed from 5 non-
pregnant control mice and 4 non-pregnant Pdx1-CreLate mice (scale bar = 20 µm). See also 
Figure S1 and Table S1. 
Figure 4 Reduced islet GLUT2 expression, loss of GSIS and protection against STZ in 
Pdx1-CreLate mice. 
(A) Glut2 mRNA signal in control versus Pdx1-CreLate islets. Gapdh was used as a reference 
gene. Data are represented as mean ± SEM n=3-4 mice per genotype, ***P<0.001. 
(B) Representative immunfluorescence staining for insulin (green signal), GLUT2 (red signal) 
and merge on pancreatic sections from control versus Pdx1-CreLate mice. Overall, the GLUT2 
signal is much weaker in Pdx1-CreLate islets compared to controls. Scale bar = 20 µm. 
(C) Ex vivo insulin secretion assay. Islets from Pdx1-CreLate and control mice were isolated 
and incubated for 1 hour with 5 mM (G5), 20mM (G20) or 20 mM D-glucose with the 
phosphodiesterase inhibitor IBMX (G20 + IBMX) Insulin release was quantified as 
percentage of insulin secreted compared to islet insulin content. Data are represented as 
mean ± SEM, n=6 mice per genotype, *P<0.05, **P<0.01. 
(D) i.p. glucose tolerance test (IPGTT) on 10-week-old Pdx1-CreLate versus control mice, n=5 
per genotype. Overnight fasted mice were injected i.p. with 2.5 mg/g BW D-glucose and 
blood glucose levels were measured at indicated time points. Data are represented as mean 
± SEM, n=5 mice per genotype, ***P<0.001, repeated measures ANOVA. 
(E) Circulating plasma insulin levels in blood samples obtained at indicated time points from 
IPGTT. Data are represented as mean ± SEM, n=5 mice per genotype. *P<0.05, ***P<0.001, 
repeated measures ANOVA.  
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(F) Multiple low-dose (MLD) treatment of the diabetogenic agent streptozotocin (STZ) in 
Pdx1-CreLate versus control mice. Mice aged 12 weeks were injected i.p. with 50mg STZ /kg 
BW for 5 consecutive days, and random fed blood glucose levels were measured at 
indicated time points. Data are represented as mean ± SEM, n=5 mice per genotype, 
*P<0.05, **P<0.01, ***P<0.001, repeated measures ANOVA. 
(G) Single high-dose of STZ in Pdx1-CreLate versus control mice. Mice were injected i.p. with 
150 mg STZ /kg BW, and fed blood glucose levels were measured. Data are represented as 
mean ± SEM, n=5-6 mice per genotype, ***P<0.001, repeated measures ANOVA. 
(H) Single high-dose (150 mg/kg BW) of STZ in Prlr-/- versus Pdx1-CreLate; Prlr-/- mice. Data 
are represented as mean ± SEM, n=3-4 mice per genotype, **P<0.01, repeated measures 
ANOVA. See also Figure S2. 
Figure 5 Growth hormone and Tph1 expression and islet serotonin immunoreactivity 
in pancreatic islets from two other commonly used mouse driver strains, MIP-GFP and 
RIP-Cre. 
(A) hGH and Tph1 mRNA signal in isolated islets from MIP-GFP and RIP-Cre mice, 
quantified as delta Ct values relative to a housekeeping mRNA signal (Hprt). Data are 
represented as mean ± SEM, n=3-6 mice per genotype, ***P<0.001. 
(B) Western blot analysis of hGH expression in islets from MIP-GFP, RIP-Cre and C57Bl6 
control mice. Predicted hGH weight = 22 kDa. GAPDH was used as a loading control. 
(C) Representative immunofluorescence micrographs show serotonin immunoreactivity in 
islets from MIP-GFP and RIP-Cre mice, whereas no signal was observed in respective 
littermate controls. Scale bar = 50 µm. 
Figure 6 Model of hGH-induced phenotypic changes in Pdx1-CreLate β cells. 
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Pdx1-promoter driven expression of the hGH minigene causes biosynthesis and secretion of 
hGH which exerts autocrine or paracrine effects after binding to PRLR on β cells.  This 
causes STAT5 phosphorylation and pregnancy-like phenotypic changes like enhanced β cell 
mass, and serotonin (5-HT) production. In addition expression of the hGH minigene causes 
pregnancy-unrelated changes such as reduction of GLUT2 expression and partial loss of 
glucose-induced insulin release. Lower GLUT2-mediated uptake and higher β cell mass 
protect against the diabetogenic effect of the β cell toxin STZ.     
Table 1: β cell specific transgenic mice generated based on a similar strategy, namely using 
the hGH minigene as transgene enhancer. The table includes the name of the strains that 
were identified and the reference of the first report. 
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Supplemental Figure Legends 
Figure S1: Pregnancy gene expression signature of control and Pdx1-creLate islets, 
Related to Figure 3. Hierarchical clustering of islets samples from control, Pdx1-creLate, 
non-pregnant C56BL/6J (NP) and pregnant (day 12.5, P12.5) C57BL/6J mice together 
with a heat map of the log2 values of the 12 genes of the pregnancy gene expression 
signature obtained by microarray. A color scale for the log2 values is shown at the right. 
See Extended Experimental Procedures. 
Figure S2: Reduced islet Glut2 expression and Impaired glucose tolerance in Pdx1-
creLate mice, Related to Figure 4. Hierarchical clustering of control and Pdx1-creLate islets 
together with a heat map of the log2 values obtained by microarray for genes involved in 
GSIS. A color scale for the log2 values is shown at the right. See Extended Experimental 
Procedures. (B) i.p. glucose tolerance test (IPGTT) on 20-week-old Pdx1-CreLate versus 
control mice. Overnight fasted mice were injected i.p. with 2.5 mg/g BW D-glucose and 
blood glucose levels were measured at indicated time points. Data are represented as 
mean ± SEM, n=5-7 mice per genotype, ***P<0.001, repeated measures ANOVA.  
Figure S3: Representative immunofluorescence micrographs show hGH 
immunoreactivity in islets from MIP-GFP and RIP-Cre mice, whereas no signal was 
observed in respective littermate controls. Scale bar = 50µm. Related to Figure 5. 
Figure S4: HPLC quantification of serotonin expressed in pmol/islet (Figure S4A) and 
molar serotonin/GABA ratios (Figure S4B) in islets from MIP-GFP, Pdx1-CreLate and their 
respective controls. Data are represented as mean ± SEM, n=4-6 mice per genotype, 
**P<0.01, ***P<0.001. Related to Figure 5. 
Figure S5: Glucose homeostasis in MIP-GFP versus CD1 controls, Related to Figure 5.. 
(A) Blood glucose levels from nine-week-old animals after an overnight fast. (B) MIP-
GFP and control animals were subjected to an IPGTT by injecting with 2.5 mg/g BW D-
glucose and blood glucose was measured at indicated time points. (B) During this 
IPGTT, plasma was taken at 0 and 30 minutes after glucose injection and insulin was 
quantified by ELISA. (C) Insulin tolerance test (ITT) on the same animal group. Data are 
represented as means ± SEM,  n=5 per genotype, *P<0.05.  
Table S1: Up- and down regulated genes in islets isolated from Pdx1-CreLate transgenic 
mice versus control mice, determined by microarray expression analysis, Related to 
Figure 3. 
 
Supplemental Experimental Procedures  
Primers and probes for quantitative RT-PCR 
GENE_ID Primer/probe  Sequence 
Car8 Forward primer 5′-AGGATATTCAATATAAGGGAA-3′ 
 Probe 5′-(6-FAM)TAATCCTAACACTTTATTACCAGACCCTCT(TAMRA)-3′ 
 Reverse primer 5′-CTTCATAGACCCAGTAAT-3′ 
Cish Forward primer 5′- AAGGTGCTAGACCCTGA -3′ 
 Probe 5′-(6-FAM)ATAGCCAAGACGTTCTCCTACCTTCGGGAAT(TAMRA)-3′ 
 Reverse primer 5′-  CTCGCTGGCTGTAATAGAA-3′ 
Cldn8 Forward primer 5′-TGGTGGATGTGGCCCTAAA-3′ 
 Probe 5′-(6-FAM)GAGGGCTTCTCCCAGCTCGCG(TAMRA)-3′ 
 Reverse primer 5′-CGCTGTGGTCCAGCCTATGT-3′ 
Ehhadh Forward primer 5′-AAGCTAGTTTGGACCATACG-3′ 
 Probe 5′-(6-FAM)AGCAAATGACAACTTCTGTGCAGGTGCTGA(TAMRA)-3′ 
 Reverse primer 5′-CTTCTGGTATCGCTGTATTTC-3′ 
Gapdh Forward primer 5’- CCCCAATGTGTCCGTCGTG-3′ 
 Reverse primer 5’- GCCTGCTTCACCACCTTCT-3′ 
Gbp8 Forward primer 5′-AAGAACGACTTGTGGAT-3′ 
 Probe 5′-(6-FAM)CATGATTCCCTGGAGAAACTACATTATGTC(TAMRA)-3′ 
 RNA extraction 
Total RNA from islets was isolated using an Absolutely RNA microprep kit (Stratagene), 
RNA from other tissues was isolated using RNA L kit (Macherey-Nagel) and RNA from 
 Reverse primer 5′-GGATTTGGTGAAGACTTT -3′ 
Glut2 Forward primer 5’- ATCCCTTGGTTCATGGTTGCTG-3′ 
 Reverse primer 5’- TCCGCAATGTACTGGAAGCAG-3′ 
Ivd Forward primer 5′-ATGTGTTGGTAATGGAAGAGA-3′ 
 Probe 5′-(6-FAM)ACTCCAACCTCTGCGTCAACCAGATTGTTC(TAMRA)-3′ 
 Reverse primer 5′-CGATGAACTCACCACTGAT-3′ 
hGH Forward primer 5’- CCAGGAGTTTGAAGAAGCCT-3′ 
 Reverse primer 5’- GGAGGTCATAGACGTTGCTGT-3′ 
Hprt Forward primer 
Reverse primer 
5’- TACGAGGAGTCCTGTTGATGTTGC-3’ 
5’- GGGACGCAGCAACTGACATTTCTA-3’ 
Lonrf3 Forward primer 5′- AATGCCAGAGAAGGACGAAGA-3′ 
 Probe 5′-(6-FAM)ACACTGGCGGTTCTTCCTCTGGAAAGCAGA(TAMRA)-3′ 
 Reverse primer 5′- AGGATACGCCGAATACCATTCAAT-3′ 
Matn2 Forward primer 5′-CAACACACCTGGCTCGTA-3′ 
 Probe 5′-(6-FAM)AGCACGGATCAGAAGACTTGCAGAATCCA(TAMRA)-3′ 
 Reverse primer 5′-AGACAAAGGAACCCAGCA-3′ 
Neb Forward primer 5′-AAAGGGACAGCCATAC-3′ 
 Probe 5′-(6-FAM)ATACTCCAGAACTTCGCAGAATCAAGAAAG(TAMRA)-3′ 
 Reverse primer 5′- ATCCATTCGATACTTAACCT -3′ 
Polr2a Forward primer 5′-GCACCACGTCCAATGATATTGTG-3′ 
 Probe 5′-(6-FAM)CTTCCGCACAGCCTCAATGCCCAGT(TAMRA)-3′ 
 Reverse primer 5′-GGAGATGACATGGTACAGTTCTCG-3′ 
Tnfrsf11b Forward primer 5′- CATCCAAGACATTGACCTCTGTG-3′ 
 Probe 5′-(6-FAM)AGCAGCTTCGTGCCTTGATGGAGAGCCTG(TAMRA)-3′ 
 Reverse primer 5′- CTTCTGGGCTGATCTTCTTCC-3′ 
Tph1 Forward primer 5′-TTCCAGGAGAATCATGTGAGC-3′ 
 Probe 5′-(6-FAM)TCAACTGTTCTCGGCTGATGTCGCAGTCA(TAMRA)-3′ 
 Reverse primer 5′-CATAACGTCTTCCTTCGCAGT-3′ 
MIN6 cells with the PureLink RNA Mini kit (Invitrogen). All extractions were performed 
according to manufacturer’s protocol. RNA quantity and quality were determined using a 
spectrophotometer (ND-1000; NanoDrop Technologies) and a bioanalyser (2100; 
Agilent), respectively. 
HPLC  
A 1 mmol/l stock standard solution of serotonin hydrochloride (Sigma-Aldrich, Steinheim, 
Germany) was prepared in a solution of 10 mmol/l hydrochloric acid (Merck, Darmstadt, 
Germany), 5.26 mmol/l sodium metabisulfite (Sigma-Aldrich) and 0.27 mmol/l EDTA 
(Sigma-Aldrich). Further dilutions were made in a mixture of four parts of a modified 
Ringer’s solution (147 mmol/l sodium chloride (Sigma-Aldrich), 4 mmol/l potassium 
chloride (Merck) and 2.3 mmol/l calcium chloride (Sigma-Aldrich)) and one part of an 
antioxidant solution (100 mmol/l acetic acid (Fisher Scientific, Loughborough, United 
Kingdom), 3.3 mmol/l L-cysteine (Sigma-Aldrich), 0.27 mmol/l EDTA and 12.5 µmol/l 
ascorbic acid (Sigma-Aldrich) (Thorré et al., 1997). A 2.5 mmol/l stock standard solution 
of GABA (Sigma-Aldrich) was prepared in 100 mmol/l hydrochloric acid and further 
dilutions in purified water.  
The method for serotonin was based on the microbore LC-ECD method described in 
(Sarre et al., 1997), using a chromatographic system with a FAMOS miocroautosampler 
of LC Packings/Dionex (Amsterdam, The Netherlands), a Gilson 307 piston pump 
(Villiers-le-Bel, France), a Dionex DEGASYS DG-1210 degasser and a DECADE II 
electrochemical detector equipped with a µ-VT03 flow cell of Antec (Zoeterwoude, The 
Netherlands). The mobile phase was a mixture of 87% (vol./vol.) aqueous buffer solution 
at pH 5.5 (100 mmol/l sodium acetate (Sigma-Aldrich), 20 mmol/l citric acid (Sigma-
Aldrich), 2 mmol/l sodium decanesulfonate (Sigma-Aldrich), 0.5 mmol/l EDTA) and 13% 
(vol./vol.) acetonitrile HPLC grade (Fisher Scientific). The flow rate of the mobile phase 
was 60 µl/min, the temperature of the autosampler tray 15°C and the injection volume 10 
µl. The stationary phase was a microbore UniJet C8 column (100 x 1.0 mm, 5 µm) from 
Bioanalytical Systems (West Lafayette, Indiana, United States). The separation and 
detection temperature were set at 35°C and the detection potential was + 450 mV vs. 
Ag/AgCl.  
The chromatographic determination of GABA in islets was based on the microbore LC-
ECD method described in (Smolders et al., 1995). The chromatographic system 
consisted of a 307 piston pump, a 231 XL sampling injector, a 402 syringe pump, all 
from Gilson (Villiers-le-Bel, France), and an LC-4C electrochemical detector equipped 
with an amperometric flow cell, supplied by Bioanalytical Systems (West Lafayette, 
Indiana, United States). The mobile phase was a mixture of 56% (vol./vol.) aqueous 
buffer solution at pH 5.0 (100 mmol/l sodium acetate, 0.1 mmol/l EDTA) and 44% 
(vol./vol.) acetonitrile, pumped with a flow rate of 100 ml/min. A two-step derivatization 
procedure was carried out at 4°C. In the first step, 3 µl working reagent A (mixture of 500 
µl 15 mmol/l o-phtaldialdehyde (Sigma-Aldrich) and 1.2 µl tert-butylthiol (Janssen 
Chimica, Geel, Belgium)) was added to 15 µl diluted sample or standard solution. 3 µl 
working reagent B (92.5 mg iodoacetamide (Sigma-Aldrich) in 500 µL methanol (Fisher 
Scientific)) was added in a second step and subsequently 10 µl was injected on a 
microbore UniJet C8 column (100 x 1.0 mm, 5 µm) from Bioanalytical Systems (West 
Lafayette, Indiana, United States). Amperometric detection was carried out at room 
temperature, applying a potential of 700 mV vs. Ag/AgCl. 
Data acquisition was performed by Clarity chromatography software version 3.0.2 from 
Data Apex (Prague, The Czech Republic).  
Hierarchical clustering with heat map  
MultiExperiment Viewer (MEV) which is part of the TM4 Microarray Software Suite was 
used to perform hierarchical clustering and to generate heat maps with the Log2 values 
for each gene (Saeed et al., 2006). The parameters used for the hierarchical clustering 
were the Euclidean distance and the average linkage method. 
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